SAFETY OF INTRAVENOUS IMMUNOGLOBULIN FOR TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA

被引:16
作者
GUTTERIDGE, CN
VEYS, P
NEWLAND, AC
机构
关键词
D O I
10.1159/000205727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:88 / 90
页数:3
相关论文
共 10 条
[1]  
BARBARA J, 1986, HOSPITAL UPDATE, V5, P697
[2]   TREATMENT OF ADULT PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA WITH INTRAVENOUS IMMUNOGLOBULIN - EFFECTS ON CIRCULATING T-CELL SUBSETS AND PWM-INDUCED ANTIBODY-SYNTHESIS INVITRO [J].
DAMMACCO, F ;
IODICE, G ;
CAMPOBASSO, N .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (01) :125-135
[3]  
IKEDA Y, 1986, LANCET, V1, P1092
[4]   HIGH-RISK OF NON-A NON-B HEPATITIS AFTER A 1ST EXPOSURE TO VOLUNTEER OR COMMERCIAL CLOTTING FACTOR CONCENTRATES - EFFECTS OF PROPHYLACTIC IMMUNE SERUM GLOBULIN [J].
KERNOFF, PBA ;
LEE, CA ;
KARAYIANNIS, P ;
THOMAS, HC .
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (03) :469-479
[5]  
LEVER AML, 1984, LANCET, V2, P1062
[6]  
MELBYE M, 1985, BR MED J, V292, P5
[7]  
MORRELL A, 1986, CLIN USE INTRAVENOUS, P177
[8]  
OCHS HD, 1985, LANCET, V1, P404
[9]  
TEDDER RS, 1985, LANCET, V1, P815
[10]  
THALER JJM, 1986, VOX SANG, V51, P253